Medical Treatments

Gene Editing Health Officials Investment Deals Acquisitions Investments Diabetes Medication Vitamins Stock Performance Pediatrics

Zimislecel Therapy Enters Phase 3 After Majority of Type 1 Diabetes Patients Go Insulin-Free

Evaluating long-term safety under immunosuppression, the phase 3 trial will generate data ahead of regulatory review.

Personalized CRISPR Therapy Sends Baby KJ Home from CHOP

NHS Adds Linzagolix as New At-Home Endometriosis Treatment

Measles Outbreak in West Texas Worsens as Unproven Treatments Raise Concerns

Sanofi Secures $1.9 Billion Deal for Dren Bio’s Innovative Autoimmune Therapy

Trump Executive Order Halts Gender-Affirming Surgeries for Minors Nationwide